Tags » Enbrel

Many Biologics used to treat Psoriasis increase the risk of skin cancer

In an article published in the Journal of the American Academy of Dermatology, individuals “with psoriasis who were treated with biologics had an increased incidence of cutaneous squamous cell carcinoma.” The risk increased by over 42% in those exposed to the TNF-alpha biololics, which include: 83 more words

Skin Cancer

Frustration Mounts as Sandoz’s Etanercept Biosimilar Launch Delayed into 2018

Call it irritation, exasperation, or frustration, but biosimilar manufacturers and payers alike are feeling it, as the fight over drug patents has barred the way to approval for yet another biosimilar for a costly biologic. 272 more words

Meeting the VA's New Rheumatologist

I drove through the snow to Sioux Falls

The place with the old red brick walls

Where it seems it’s the norm

For the staff to be warm… 681 more words

Ankylosing Spondylitis

Damn It, I'm Going! Traveling with Arthritis

This Autumn I fulfilled a dream of travel, and was honored to have my article posted by the Arthritis National Research Foundation . Thank you for the opportunity to contribute! 788 more words
Rheumatoid Arthritis

Novartis's biosimilar equivalent to Amgen's Enbrel

Novartis’s division Sandoz’s biosimilar etanercept is equivalent to the originator product, Enbrel, in more than 500 adult patients over 52 weeks,the confirmatory clinical safety and efficacy study shows. 390 more words

News

Expanded Use Of ENBREL® (etanercept) is Approved by FDA for Treating Children with Chronic Moderate-To-Severe Plaque Psoriasis

Nov. 4, 2016

Amgen has announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for the expanded use of ENBREL® (etanercept). 241 more words

News